No Data
BAIYUNSHAN PH (00874.HK) subsidiary's pharmaceutical has passed the consistency evaluation of generic drugs.
Gelonghui, March 28 | BAIYUNSHAN PH (00874.HK) announced that recently, its holding subsidiary Guangzhou BAIYUNSHAN TIANXIN Pharmaceutical Co., Ltd. received the "Notice of Approval for Pharmaceutical Supplementary Application" issued by the National Medical Products Administration, indicating that injectable ampicillin sodium (1.0g, 0.5g) has passed the consistency evaluation of generic drug quality and efficacy. Tianxin Pharmaceutical's injectable ampicillin sodium (1.0g, 0.5g) was launched in 2002. In 2023, Tianxin Pharmaceutical submitted the consistency evaluation for injectable ampicillin sodium (1.0g, 0.5g) to the National Medical Products Administration on November 28.
BAIYUNSHAN PH (00874.HK): Hepatitis B detox capsules and others have received approval for supplementary applications.
On March 28, Glonhui reported that BAIYUNSHAN PH (00874.HK) announced that its subsidiary, Guangzhou BAIYUNSHAN PH Pharmaceutical Group Co., Ltd. BAIYUNSHAN PH Pharmaceutical Factory (hereinafter referred to as "BAIYUNSHAN PH Pharmaceutical Factory"), received the "Pharmaceutical Supplement Application Approval Notice" issued by the National Medical Products Administration. This time, BAIYUNSHAN PH Pharmaceutical Factory has obtained the "Pharmaceutical Supplement Application Approval Notice" for Hepatitis B detoxification capsules and Rhododendron capsules, which improves the safety information and other details of the above pharmaceuticals, aiding in their safe, effective, and rational use, and enhancing the market competitiveness of the product. This time, the "Pharmaceutical Supplement Application Approval Notice" has been obtained.
BAIYUNSHAN PH (600332.SH): Injection of sodium ampicillin has passed the consistency evaluation for generic drugs.
On March 28, Gelonghui reported that BAIYUNSHAN PH (600332.SH) announced that its holding subsidiary, Guangzhou BAIYUNSHAN PH Tianxin Pharmaceutical Co., Ltd., received the "Pharmaceutical Supplement Application Approval Notice" issued by the National Medical Products Administration, indicating that the injectable Ampicillin Sodium (1.0g, 0.5g) has passed the consistency evaluation of quality and efficacy for generic drugs. Injectable Ampicillin Sodium is a broad-spectrum semi-synthetic penicillin used for respiratory infections, gastrointestinal infections, urinary tract infections, soft tissue infections, endocarditis, meningitis, sepsis, and other infections caused by sensitive bacteria.
Baiyunshan Pharma's Subsidiary Gets Nod to Trial Yupingfeng Tea Bag as Treatment For Hypothyroidism
The subsidiary of BAIYUNSHAN PH (00874.HK), YUPINGFENG, has obtained approval for clinical trials for its tea bags.
On March 25, GELONGHUI reported that BAIYUNSHAN PH (00874.HK) announced that recently, its subsidiary Guangzhou BAIYUNSHAN CHEN LIJI Pharmaceutical Factory Co., Ltd. (hereinafter referred to as "CHEN LIJI Pharmaceutical Factory") received the "Approval Notification for Clinical Trials of Pharmaceuticals" issued by the National Medical Products Administration. According to relevant regulations, after review, the clinical trial application for YUPINGFENG tea bags submitted on December 30, 2024, meets the relevant requirements for pharmaceutical registration. Based on further improvements to the clinical trial plan, the approval is granted for this product to conduct trials for subclinical hypothyroidism and clinical hypothyroidism in patients with Hashimoto's thyroiditis who have normal thyroid function after LT4 treatment, along with spleen and lung qi deficiency syndrome.
BAIYUNSHAN PH (600332.SH): The subsidiary has received the approval notification for the clinical trial of a drug.
On March 25, Gelonghui reported that BAIYUNSHAN PH (600332.SH) announced that its subsidiary Guangzhou BAIYUNSHAN Chenlij Medicine Factory Co., Ltd. (referred to as "Chenlij Medicine Factory") received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration. The functions and indications of Yupingfeng tea bags are to tonify qi, consolidate the exterior, and stop sweating. It is used for deficiencies of the exterior leading to spontaneous sweating, aversion to wind, pale complexion, or symptoms of fatigue in people with spleen and lung qi deficiency prone to wind evil. This product is an already marketed Traditional Chinese Medicine compound preparation, and this time aims to add functions and indications for the improvement of symptoms in subclinical hypothyroidism and clinical hypothyroidism in Hashimoto's thyroiditis patients treated with LT4 to achieve normal thyroid function.
Returns At Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Appear To Be Weighed Down
